188Re or 90Y-labelled anti-CD66 antibody as part of a dose-reduced conditioning regimen for patients with acute leukaemia or myelodysplastic syndrome over the age of 55: results of a phase I-II study

Mark Ringhoffer, Norbert Blumstein, Bernd Neumaier, Gerhard Glatting, Stephanie von Harsdorf, Inga Buchmann, Markus Wiesneth, Jörg Kotzerke, Thorsten Zenz, Andreas K Buck, Peter Schauwecker, Stephan Stilgenbauer, Hartmut Döhner, Sven N Reske, Donald Bunjes

Fingerprint

Dive into the research topics of '188Re or 90Y-labelled anti-CD66 antibody as part of a dose-reduced conditioning regimen for patients with acute leukaemia or myelodysplastic syndrome over the age of 55: results of a phase I-II study'. Together they form a unique fingerprint.

INIS